Previous Close | 7.30 |
Open | 7.26 |
Bid | 2.86 x 900 |
Ask | 7.18 x 2200 |
Day's Range | 6.81 - 7.38 |
52 Week Range | 6.81 - 11.25 |
Volume | |
Avg. Volume | 6,113 |
Market Cap | 92.036M |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | 340.50 |
EPS (TTM) | 0.02 |
Earnings Date | Mar 09, 2022 - Mar 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.67 |
HACKENSACK, NJ / ACCESSWIRE / May 3, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced today that its Lumin Bioinformatics Platform has been selected as a finalist for the ‘Best in Show' Competition at the upcoming Bio-IT World Conference & Expo.
Champions Oncology (NASDAQ:CSBR) has had a rough month with its share price down 7.0%. However, stock prices are...
HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its third quarter of fiscal 2022, ended January 31, 2022.